{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:55:32Z","timestamp":1767984932772,"version":"3.49.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086114","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T21:41:16Z","timestamp":1391031676000},"page":"e86114","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Brittany B.","family":"Dennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Bawor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Sohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","year":"1998","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1360-0443.2011.03707.x","article-title":"Use of other opioids during methadone therapy: a population-based study","volume":"107","author":"P Kurdyak","year":"2012","journal-title":"Addiction"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta\u00adanalysis","volume":"93","author":"LA Marsch","year":"1998","journal-title":"Addiction"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"R Cornish","year":"2010","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state- wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"L Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"A Gibson","year":"2008","journal-title":"Addiction"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"c3172","DOI":"10.1136\/bmj.c3172","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"341","author":"J Kimber","year":"2010","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004714-200104000-00016","article-title":"Cytochrome P450 2D6 genotype and methadone steady-state concentrations","volume":"21","author":"CB Eap","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2012.08.003","article-title":"Factors associated with mortality among heroin users after seeking treatment with methadone: a population-based cohort study in Taiwan","volume":"44","author":"CL Huang","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"E Oviedo-Joekes","year":"2009","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"RE Johnson","year":"2000","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(01)00199-5","article-title":"Evaluation of an alternative program for MMTP drop\u00adouts: impact on treatment re-entry","volume":"66","author":"MF Goldstein","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.01.013","article-title":"Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users","volume":"79","author":"F Termorshuizen","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"D Goldman","year":"2005","journal-title":"Nature reviews Genetics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","article-title":"CYP2B6 and OPRM1 gene variations predict methadone\u00adrelated deaths","volume":"16","author":"H Bunten","year":"2011","journal-title":"Addict Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2006.12.018","article-title":"Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment","volume":"89","author":"J Perez de los Cobos","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"S Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"S Crettol","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)\u00admethadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"CB Eap","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e19527","DOI":"10.1371\/journal.pone.0019527","article-title":"Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response","volume":"6","author":"F Fonseca","year":"2011","journal-title":"PloS one"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/ddn122","article-title":"ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence","volume":"17","author":"O Levran","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref22","article-title":"CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction","author":"O Levran","year":"2011","journal-title":"Addict Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.12.69","article-title":"UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients","volume":"13","author":"JN Tian","year":"2012","journal-title":"Pharmacogenomics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/JCP.0b013e318222b5dd","article-title":"CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S\u00adenantiomer","volume":"31","author":"SC Wang","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2217\/pgs.11.103","article-title":"Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients","volume":"12","author":"CH Chen","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/tpj.2010.37","article-title":"beta-Arrestin2 influences the response to methadone in opioid-dependent patients","volume":"11","author":"B Oneda","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.pnpbp.2008.07.009","article-title":"Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment","volume":"32","author":"S Crettol","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03256370","article-title":"Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes","volume":"14","author":"F Fonseca","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1601-183X.2007.00386.x","article-title":"BDNF variability in opioid addicts and response to methadone treatment: preliminary findings","volume":"7","author":"R de Cid","year":"2008","journal-title":"Genes Brain Behav"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2217\/pgs.11.96","article-title":"Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients","volume":"12","author":"CC Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ajmg.b.31208","article-title":"Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies","volume":"156B","author":"D Chen","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref32","first-page":"9","article-title":"Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta\u00adanalysis","volume":"2","author":"JK Coller","year":"2009","journal-title":"Pharmgenomics Pers Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clpt.2006.09.011","article-title":"ABCB1 genetic variability and methadone dosage requirements in opioid\u00addependent individuals","volume":"80","author":"JK Coller","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.pnpbp.2009.07.016","article-title":"Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence","volume":"33","author":"A Benyamina","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphism","volume":"12","author":"Y Li","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clpt.2005.09.010","article-title":"Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action","volume":"79","author":"J Lotsch","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"J Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta\u00adanalysis of Observational Studies in Epidemiology","volume":"283","author":"DFBJ Stroup","year":"2000","journal-title":"JAMA"},{"key":"ref39","unstructured":"Wells GA SB, O&apos;Connell D, Peterson J, Welch V, Losos M, et al (2009) The Newcastle\u00adOttawa Scale (NOS) for assessing the quality if nonrandomized studies in meta\u00adanalyses. Available from URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwohrica\/programs\/clinical_epidemiology\/oxfordhtm\" xlink:type=\"simple\">http:\/\/wwwohrica\/programs\/clinical_epidemiology\/oxfordhtm<\/ext-link>. Accessed April 2012."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/FPC.0b013e328320a3fd","article-title":"Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution","volume":"19","author":"A Doehring","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/tpj.2011.6","article-title":"Nerve growth factor beta polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment","volume":"12","author":"O Levran","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"ref42","unstructured":"Collaboration TC (2011) The Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0; Higgins JPT, and Green, S., editor."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref44","first-page":"53","article-title":"ABCB1 haplotype and OPRM1 118A &gt; G genotype interaction in methadone maintenance treatment pharmacogenetics","volume":"5","author":"DT Barratt","year":"2012","journal-title":"Pharmgenomics Pers Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.clpt.6100305","article-title":"No influence of ABCB1 haplotypes on methadone dosage requirement","volume":"83","author":"S Crettol","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref46","first-page":"39","article-title":"Pharmacokinetic and pharmacogenetic factors influencing methadone plasma levels","volume":"9","author":"SE Crettol","year":"2007","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"ref47","unstructured":"Somogyi AA, Coller JK, Foster DBF, Li Y (2011) Role of CYP2B6 polymorphism in the metabolism and pharmacokinetics of methadone enantiomers. In: Ltd BP, editor. Basic and Clinical Pharmacology and Toxicology Conference: 10th Congress of the European Association for Clinical Pharmacology and Therapeutics Conference Budapest, Hugary. pp. 109, 132."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0b013e3180592ad2","article-title":"Increased (R)\u00admethadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients","volume":"27","author":"C Uehlinger","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"ref49","unstructured":"Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences 2nd ed; Associates LE, editor. NJ."},{"key":"ref50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"D Goldman","year":"2005","journal-title":"Nat Rev Genet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.110.236067","article-title":"Strategic approaches to unraveling genetic causes of cardiovascular diseases","volume":"108","author":"AJ Marian","year":"2011","journal-title":"Circ Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10826084.2013.800119","article-title":"Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in british columbia during its expansion period from 1998\u20132006","volume":"48","author":"B Sharif","year":"2013","journal-title":"Subst Use Misuse"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e59419","DOI":"10.1371\/journal.pone.0059419","article-title":"Functional impact of ABCB1 variants on interactions between P-glycoprotein and methadone","volume":"8","author":"CC Hung","year":"2013","journal-title":"PloS one"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N\u00addemethylation by cytochrome P4502B6 and 2C19","volume":"16","author":"JG Gerber","year":"2004","journal-title":"Chirality"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism","volume":"321","author":"RA Totah","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"RA Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/dmd.112.050625","article-title":"Methadone N\u00addemethylation by the common CYP2B6 allelic variant CYP2B6.6","volume":"41","author":"S Gadel","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinternmed.2010.26","article-title":"Substitution of (R,S)-methadone by (R)\u00admethadone: Impact on QTc interval","volume":"170","author":"N Ansermot","year":"2010","journal-title":"Arch Intern Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000167043","article-title":"The effects of chiral isolates of methadone on the cardiac potassium channel IKr","volume":"113","author":"C Lin","year":"2009","journal-title":"Cardiology"},{"key":"ref60","article-title":"Grade guidelines 6. Rating the quality of evidence \u2013 imprecision","author":"OA Guyatt G","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"ref61","first-page":"389","article-title":"[Weight changes of patients in methadone maintenance treatment during four years period]","volume":"151","author":"L Okruhlica","year":"2012","journal-title":"Cas Lek Cesk"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta\u2013analysis of retention in methadone maintenance by dose and dosing strategy","volume":"35","author":"YP Bao","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/aje\/kwp186","article-title":"Proportional hazards frailty models for recurrent methadone maintenance treatment","volume":"170","author":"B Nosyk","year":"2009","journal-title":"Am J Epidemiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0376-8716(96)01230-6","article-title":"Retention in a low-threshold methadone maintenance program","volume":"41","author":"M Torrens","year":"1996","journal-title":"Drug Alcohol Depend"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Mattick Richard P, Breen C, Kimber J, Davoli M (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews: John Wiley &amp; Sons, Ltd.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.addbeh.2011.07.019","article-title":"A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences","volume":"36","author":"L Jimenez-Trevino","year":"2011","journal-title":"Addict Behav"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsat.2011.05.001","article-title":"Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study","volume":"41","author":"G Cousins","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy","volume":"35","author":"YP Bao","year":"2009","journal-title":"The American journal of drug and alcohol abuse"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7517-2-25","article-title":"Health problems and help\u2013seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion?","volume":"2","author":"J Sheridan","year":"2005","journal-title":"Harm Reduct J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:56:17Z","timestamp":1588996577000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086114"}},"subtitle":[],"editor":[{"given":"Huiping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086114","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]}}}